AU Patent

AU2013205160B2 — Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

Assigned to Vertex Pharmaceuticals Inc · Expires 2016-05-19 · 10y expired

What this patent protects

The present invention relates to presses for preparing Cystic Fibrosis transmembrane conductance regulator (CFTR) correctors such as the compound 3-(6-( (2,2difliuorobenzo [d] [1.3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin 2-yl)benzoic acid (Compound 1) in substantial…

USPTO Abstract

The present invention relates to presses for preparing Cystic Fibrosis transmembrane conductance regulator (CFTR) correctors such as the compound 3-(6-( (2,2difliuorobenzo [d] [1.3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin 2-yl)benzoic acid (Compound 1) in substantially free form useful in the treatment of cystic fibrosis, F O N N N CO 2 H Compound 1.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013205160B2
Jurisdiction
AU
Classification
—
Expires
2016-05-19
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.